Articles Tagged With: COVID-19
-
U.S. N95 Respirator Supply Finally Deemed Adequate
Federal regulators remove devices from shortage list.
-
Predicting Coma Recovery in Critically Ill COVID-19 Patients
The COVID-19 pandemic presented us with an unprecedented number of critically ill patients with coma. These investigators determined that the degree of hypoxemia determined the depth and duration of coma, but recovery was much better than expected and could be delayed by several weeks.
-
CMS Issues First Fines for Noncompliance with Transparency Rule
CMS has issued the first fines for violations of the Hospital Price Transparency Rule, and more penalties are expected. The first two hospitals fined for violations of the rule, both in Georgia, received written warnings and were allowed more than four months to bring their operations in compliance with the rule.
-
OCR Releases Guidance on Audio-Only Telehealth
The Office for Civil Rights (OCR) recently issued guidance on how covered entities can use audio-only telehealth services in compliance with HIPAA. In line with what is referred to as the common carrier exception, OCR clarified the Security Rule does not apply to audio-only telehealth services provided by a covered entity that is using a standard landline.
-
Outcomes of COVID-19-Associated Acute Myocarditis
In a review of COVID-19-associated acute myocarditis, investigators learned it is a rare complication that can occur without concomitant pneumonia, and frequently presents as cardiogenic shock. With supportive therapy, the short-term mortality rate is low.
-
COVID-19 Infection Course Worse in Patients Receiving Anti-CD20 Treatment
In this retrospective cohort, patients receiving anti-CD20 treatment had worse clinical outcomes, including mortality, in addition to longer durations of infectivity and higher rates of relapse.
-
Feds Order Bivalent Vaccines with Omicron
The Biden administration is securing orders for bivalent vaccines that are expected to combine the original Wuhan strain with omicron subvariants BA.4 and BA.5.
-
IP ‘Ambassadors’ Extend Program’s Pandemic Reach
Some infection preventionists have extended their reach by recruiting infection control champions or ambassadors to keep their colleagues updated on the ongoing changes and recommendations in the pandemic response.
-
Vaccinate Children Against MIS-C, a Serious Post-COVID Syndrome
COVID-19 vaccination can greatly reduce multisystem inflammatory syndrome in children, a rare but serious complication associated with SARS-CoV-2 infection, researchers are finding.
-
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)
Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.